Search Ontology:
ChEBI
(2R,3S,4S,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,6-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
- Term ID
- CHEBI:154671
- Synonyms
-
- 2-deoxy-2-sulfoamino-alpha-D-gluco-hexopyranosyl-(1->4)-2-O-sulfo-L-ido-hexopyranuronic acid
- GlcNS(a1-4)IdoA2S
- WURCS=2.0/2,2,1/[a2121A-1x_1-5_2*OSO/3=O/3=O][a2122h-1a_1-5_2*NSO/3=O/3=O]/1-2/a4-b1
- Definition
- References
-
- GlyGen:G89699BW
- GlyTouCan:G89699BW
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from (2R,3S,4S,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,6-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
Phenotype where environments contain (2R,3S,4S,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,6-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
Phenotype modified by environments containing (2R,3S,4S,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,6-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
Human Disease Model